Literature DB >> 16868622

Balloon kyphoplasty for vertebral compression fracture using a unilateral balloon tamp via a uni-pedicular approach: technical note.

Brian L Hoh1, James D Rabinov, Johnny C Pryor, Joshua A Hirsch.   

Abstract

OBJECTIVE: Percutaneous balloon kyphoplasty, like percutaneous vertebroplasty is a therapeutic intervention for painful osteoporotic vertebral body compression fracture. The procedure involves placement of bilateral inflatable balloon tamps in the fractured vertebral body via a bilateral transpedicular or bilateral extra-pedicular approach. We describe performance of balloon kyphoplasty using a unilateral, single, balloon tamp via a unilateral transpedicular approach. The advantages of a unilateral approach are reducing the risk, albeit low, of pedicle fracture, medial transgression of the pedicle and/or transgression into the spinal canal, nerve injury, cement extravasation along the cannula tract, and spinal epidural hematoma. Additionally, operative and anesthesia time is reduced, as well as the costs of balloon tamps, cannulas, and needles. CASE ILLUSTRATION: An 83-year-old woman with osteoporosis presented with severe lower thoracic back pain which occurred when she bent over to lift a heavy box. The pain was reproducible on palpation of the T-11 spinous process. A spine MRI with STIR (short tau inversion recovery) sequence demonstrated a subacute T-11 vertebral body compression fracture with associated edema. A T-11 balloon kyphoplasty was performed using a unilateral inflatable balloon tamp via a unilateral transpedicular approach. The patient reported immediate relief of pain and improvement of visual analog score (VAS) for pain from preoperative 10 to postoperative 2. She was able to ambulate postoperatively whereas preoperatively she was inhibited by pain.
CONCLUSION: Balloon kyphoplasty can be performed using a unilateral balloon tamp via a unilateral pedicular approach. The key is a medial needle trajectory with a final balloon position in the midline of the vertebral body.

Entities:  

Year:  2004        PMID: 16868622

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  6 in total

1.  Results, experience and technical points learnt with use of the SKy Bone Expander kyphoplasty system for osteoporotic vertebral compression fractures: a prospective study of 40 patients with a minimum of 12 months of follow-up.

Authors:  Leon Siang Shen Foo; William Yeo; Stephanie Fook; Chang Ming Guo; John Li Tat Chen; Wai Mun Yue; Seang Beng Tan
Journal:  Eur Spine J       Date:  2007-07-21       Impact factor: 3.134

2.  The clinical application and efficacy of percutaneous kyphoplasty via unilateral pedicular approach guided by CT image measurement.

Authors:  Weifeng Zhai; Yongwei Jia; Jianjie Wang; Liming Cheng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Clinical and radiological comparison of unipedicular versus bipedicular balloon kyphoplasty for the treatment of vertebral compression fractures.

Authors:  B-K Song; J-P Eun; Y-M Oh
Journal:  Osteoporos Int       Date:  2009-03-04       Impact factor: 4.507

4.  Double-Balloon Kyphoplasty Results in Better Radiographic Outcomes Than a Single-Balloon Kyphoplasty in Treating Osteo-Porotic Spinal Fractures.

Authors:  Raphael Lotan; Yaron Haimovich; Louis Schorr; Adam Lee Goldstein; Oded Hershkovich
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

Review 5.  Robot-Assisted Kyphoplasty Improves Clinical and Radiological Features Better Than Fluoroscopy-Assisted Kyphoplasty in the Treatment of Vertebral Compression Fractures: A Meta-Analysis.

Authors:  Hongwei Yu; Gan Luo; Bin Yu; Tianwei Sun; Qiong Tang; Yutao Jia
Journal:  Front Surg       Date:  2022-07-05

6.  Percutaneous intervertebral bridging cementoplasty for adjacent multilevel osteoporotic thoracolumbar fractures with vertebral endplate-disc complex injury: technical note.

Authors:  Song Wang; Chunyan Duan; Han Yang; Jianping Kang; Qing Wang
Journal:  Sci Rep       Date:  2020-09-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.